DESCRIPTION
The Florida DLMP Pathology Department is interested in submitting the Pathology Journal Club Conference for CME approval. It is a conference that takes place on the second Friday of every month where pathologists review peer-reviewed articles as well as new research articles for new developments in subdivisions within pathology (example: New development of breast cancer ancillary tests, treatments, and diagnostic criteria to breast cancer). 

TARGET AUDIENCE
This course is intended primarily for Physicians and Resident Fellows.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to: 

1. Apply new advances in the practice of pathology to their daily clinical work.
2. Have an understanding in the recent technologic, molecular, digital and other developments in pathology.
3. Identify new developments and further pathology knowledge, to include but not limited to diagnosing challenging and newly described entities, pertinent treatment plans, diagnostic pitfalls and criteria, in the various subspecialties of pathology.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA
The American Osteopathic Association designates this program for a maximum of 1.00 AOA Category 2-A credits.

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies: 
Miglena Komforti, D.O.: Consultant - Agilent

Relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:
J. Kenneth Schoolmeester, MD; Nicole Donnelly; Teri Green; Lorraine Hutcherson, Elizabeth Montgomery, Meredith Brown, Hamza Ashmila, M.B., Ch.B.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here. 

CE Broker Code: 23R00685-A

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

COURSE DIRECTOR
Miglena Komforti, D.O.

QUESTIONS?
Contact Nicole Donnelly